1. Bioactive Glasses Modulate Anticancer Activity and Other Polyphenol-Related Properties of Polyphenol-Loaded PCL/Bioactive Glass Composites.
- Author
-
Dziadek M, Dziadek K, Checinska K, Zagrajczuk B, and Cholewa-Kowalska K
- Subjects
- Humans, Cell Line, Tumor, Apoptosis drug effects, Cell Proliferation drug effects, Polyesters chemistry, Biocompatible Materials chemistry, Biocompatible Materials pharmacology, Antioxidants chemistry, Antioxidants pharmacology, Polyphenols chemistry, Polyphenols pharmacology, Glass chemistry, Antineoplastic Agents chemistry, Antineoplastic Agents pharmacology
- Abstract
In this work, bioactive glass (BG) particles obtained by three different methods (melt-quenching, sol-gel, and sol-gel-EISA) were used as modifiers of polyphenol-loaded PCL-based composites. The composites were loaded with polyphenolic compounds (PPh) extracted from sage ( Salvia officinalis L.). It was hypothesized that BG particles, due to their different textural properties (porosity, surface area) and surface chemistry (content of silanol groups), would act as an agent to control the release of polyphenols from PCL/BG composite films and other significant properties associated with and affected by the presence of PPh. The polyphenols improved the hydrophilicity, apatite-forming ability, and mechanical properties of the composites and provided antioxidant and anticancer activity. As the BG particles had different polyphenol-binding capacities, they modulated the kinetics of polyphenol release from the composites and the aforementioned properties to a great extent. Importantly, the PPh-loaded materials exhibited multifaceted and selective anticancer activity, including ROS-mediated cell cycle arrest and apoptosis of osteosarcoma (OS) cells (Saos-2) via Cdk2-, GADD45G-, and caspase-3/7-dependent pathways. The materials showed a cytotoxic and antiproliferative effect on cancerous osteoblasts but not on normal human osteoblasts. These results suggest that the composites have great potential as biomaterials for treating bone defects, particularly following surgical removal of OS tumors.
- Published
- 2024
- Full Text
- View/download PDF